Streetbeat News

Stock Prices

LLY

Eli Lilly & Co. plans to test its weight-loss drugs for potential use in treating addictive behaviors such as alcohol abuse, smoking, and drug addiction, as announced by CEO Dave Ricks.

Portfolio Pulse from

December 10, 2024 | 8:45 pm

KYTX

Robbins LLP has announced a class action lawsuit against Kyverna Therapeutics, Inc. (NASDAQ: KYTX) and certain executives related to the company's IPO. Kyverna is a biopharmaceutical company developing cell therapies for autoimmune diseases.

Portfolio Pulse from

December 10, 2024 | 8:45 pm

CELH

Robbins Geller Rudman & Dowd LLP has announced a class action lawsuit against Celsius Holdings, Inc. (NASDAQ: CELH) for investors who purchased stock between February 29, 2024, and September 4, 2024. Investors with substantial losses have until January 21, 2025, to seek appointment as lead plaintiff.

Portfolio Pulse from

December 10, 2024 | 8:45 pm

SYM

Symbotic Inc. (NASDAQ:SYM) is facing a securities fraud lawsuit filed by Bleichmar Fonti & Auld LLP. The lawsuit targets the company and certain senior executives for potential violations of federal securities laws. Investors are advised to seek more information before the class action deadline on February 3.

Portfolio Pulse from

December 10, 2024 | 8:45 pm

ASML

ASML Holding N.V. is facing a securities fraud lawsuit filed by Bleichmar Fonti & Auld LLP, with a class action deadline set for January 13. The lawsuit targets ASML and certain senior executives for potential violations of federal securities laws.

Portfolio Pulse from

December 10, 2024 | 8:45 pm

ACHC

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) is facing a securities fraud lawsuit filed by Bleichmar Fonti & Auld LLP. Investors have until December 16, 2024, to join the class action.

Portfolio Pulse from

December 10, 2024 | 8:45 pm

NOK

Nokia Corporation has repurchased 872,093 of its own shares at an average price of EUR 4.18 per share as part of a buyback program. This initiative aims to offset the dilution from new shares issued to Infinera Corporation shareholders and related incentives.

Portfolio Pulse from

December 10, 2024 | 8:45 pm

OZ

Belpointe PREP, a REIT focusing on opportunity zones, is in an early growth phase with execution risks. Its shares trade at a discount to NAV, but the gap has narrowed, making it less attractive for new investments. The fund relies heavily on future redevelopment success.

Portfolio Pulse from

December 10, 2024 | 8:45 pm

ALB

LUV

The article discusses how a moderately growing economy could benefit certain volatile stocks, including Southwest Airlines and Albemarle.

Portfolio Pulse from

December 10, 2024 | 8:30 pm

WBA

Walgreens Boots Alliance (WBA) shares surged by 20% on Tuesday.

Portfolio Pulse from

December 10, 2024 | 8:30 pm